Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 21.54% is 12% above its 5-year average of 19.27%, near the high end of its 5-year range (15.44%–22.20%).
As of the fiscal period ended Wednesday, December 31, 2025. 1.51% below its 12-month average of 21.87%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
21.54%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
21.87%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
20.30%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
19.27%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
16.93%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
14.60%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-1.51%
CURRENT VS 3Y AVG
+6.08%
CURRENT VS 5Y AVG
+11.81%
CURRENT VS 10Y AVG
+27.22%
CURRENT VS 15Y AVG
+47.52%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
8.53%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+152.52%
vs the sector median at left
Zoetis Inc.
Market Cap
$32.40B
Return on Invested Capital (ROIC)
21.54%
TTM Avg
21.87%
3Y Avg
20.30%
5Y Avg
19.27%
Market Cap
$33.22B
Return on Invested Capital (ROIC)
5.69%
TTM Avg
6.03%
3Y Avg
3.95%
5Y Avg
3.95%
Market Cap
$31.49B
Return on Invested Capital (ROIC)
16.61%
TTM Avg
13.40%
3Y Avg
11.07%
5Y Avg
9.62%
Market Cap
$30.74B
Return on Invested Capital (ROIC)
-13.41%
TTM Avg
-4.17%
3Y Avg
-0.53%
5Y Avg
0.76%
Market Cap
$30.72B
Return on Invested Capital (ROIC)
8.84%
TTM Avg
8.56%
3Y Avg
8.37%
5Y Avg
9.38%
Market Cap
$30.60B
Return on Invested Capital (ROIC)
19.56%
TTM Avg
18.66%
3Y Avg
17.73%
5Y Avg
16.77%
Market Cap
$29.99B
Return on Invested Capital (ROIC)
6.62%
TTM Avg
7.71%
3Y Avg
8.64%
5Y Avg
10.90%
Market Cap
$28.62B
Return on Invested Capital (ROIC)
35.46%
TTM Avg
38.26%
3Y Avg
37.51%
5Y Avg
36.01%
Market Cap
$27.50B
Return on Invested Capital (ROIC)
13.74%
TTM Avg
4.84%
3Y Avg
-6.97%
5Y Avg
-13.43%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zoetis Inc. (ZTS) | $32.40B | 21.54% | 21.87% | 20.30% | 19.27% |
| Medline Inc. (MDLN)vs › | $33.22B | 5.69% | 6.03% | 3.95% | 3.95% |
| DexCom, Inc. (DXCM)vs › | $31.49B | 16.61% | 13.40% | 11.07% | 9.62% |
| Centene Corp. (CNC)vs › | $30.74B | -13.41% | -4.17% | -0.53% | 0.76% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $30.72B | 8.84% | 8.56% | 8.37% | 9.38% |
| ResMed Inc. (RMD)vs › | $30.60B | 19.56% | 18.66% | 17.73% | 16.77% |
| Biogen Inc. (BIIB)vs › | $29.99B | 6.62% | 7.71% | 8.64% | 10.90% |
| Mettler-Toledo International Inc. (MTD)vs › | $28.62B | 35.46% | 38.26% | 37.51% | 36.01% |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $27.50B | 13.74% | 4.84% | -6.97% | -13.43% |
| IQVIA Holdings Inc. (IQV)vs › | $38.68B | 8.23% | 8.41% | 8.23% | 6.99% |
ROIC
21.5%
ROE
81.8%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 21.54% |
| 2024-12-31 | 22.20% |
| 2023-12-31 | 19.73% |
| 2022-12-31 | 17.75% |
| 2021-12-31 | 18.93% |
| 2020-12-31 | 15.44% |
| 2019-12-31 | 16.42% |
| 2018-12-31 | 16.57% |
| 2017-12-31 | 13.03% |
| 2016-12-31 | 14.34% |
| 2015-12-31 | 10.30% |
| 2014-12-31 | 12.60% |
| 2013-12-31 | 11.60% |
| 2012-12-31 | 10.06% |
| 2011-12-31 | 8.84% |
| 2010-12-31 | 4.27% |
| 2009-12-31 | 0.00% |
